Insider Transactions Reported by 2 Insiders of CASI Pharmaceuticals, Inc.

Symbol
CASIF on OTC
Location
Beijing, China

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

CASI Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
James Huang Director $1,087,189 18 Mar 2026
Wei-Wu He Director, 10%+ Owner $611,566 18 Mar 2026

Recent Insider Transactions by Companies or Individuals for CASI Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Wei-Wu He CASIF Ordinary Share 0 637,644 18 Mar 2026 See Footnote
Wei-Wu He CASIF Ordinary Share 0 100,000 18 Mar 2026 See Footnote
Wei-Wu He CASIF Ordinary Share 0 300,000 18 Mar 2026 See Footnote
Wei-Wu He CASIF Ordinary Share 0 753,234 18 Mar 2026 See Footnote
Wei-Wu He CASIF Ordinary Share 0 44,107 18 Mar 2026 See Footnote
Wei-Wu He CASIF Ordinary Share 0 1,910,550 18 Mar 2026 Direct
James Huang CASIF Ordinary Shares 0 4,529,956 18 Mar 2026 See Footnote
* An asterisk sign (*) next to the price indicates that the price is likely invalid.